Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Understand the rationale behind cash back rewards on credit cards. Learn how to take advantage of these offers.
26,130 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
A plan to exempt overtime from income tax might attract attention for rewarding hard work, but it risks fairness, rev...
Oil is rising and energy stocks are drawing cautious buyers. This guide shows two resilient oil producers you could b...
The MDST ETF continues its monthly distribution streak, trading near the $29 mark while offering a high 9.4% yield wi...
A healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...
Seeking dependable income in a volatile market? This article highlights three energy dividend stocks reliable for 202...
The S&P 500 has delivered double-digit gains for years, but a new era may bring slower growth and higher costs. This ...
A major energy infrastructure company is funding AI data-center expansion with a generous dividend, while C3.AI conte...
Could 2026 bring a surprise policy pivot? This guide explains why the Fed might hike instead of cutting, how that sce...
A sharp intraday move in uranium miners has investors asking what really sparked the rally. This article dives into t...
This article breaks down surf mobility (SRFM) earnings in plain language. Learn what the SRFM earnings transcript rev...
Hydrogen stocks have captured attention in 2026. This guide pits Plug Power against FuelCell Energy, cutting through ...